ATE196802T1 - Zielspezifische screens und ihre verwendung zur ermittelung von kleinen organischen molekularen pharmakophoren - Google Patents
Zielspezifische screens und ihre verwendung zur ermittelung von kleinen organischen molekularen pharmakophorenInfo
- Publication number
- ATE196802T1 ATE196802T1 AT95930144T AT95930144T ATE196802T1 AT E196802 T1 ATE196802 T1 AT E196802T1 AT 95930144 T AT95930144 T AT 95930144T AT 95930144 T AT95930144 T AT 95930144T AT E196802 T1 ATE196802 T1 AT E196802T1
- Authority
- AT
- Austria
- Prior art keywords
- small organic
- antibodies
- target
- parts
- domains
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28608494A | 1994-08-03 | 1994-08-03 | |
US08/473,105 US6010861A (en) | 1994-08-03 | 1995-06-07 | Target specific screens and their use for discovering small organic molecular pharmacophores |
PCT/US1995/010182 WO1996004557A2 (en) | 1994-08-03 | 1995-08-02 | Target specific screens and their use for discovering small organic molecular pharmacophores |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE196802T1 true ATE196802T1 (de) | 2000-10-15 |
Family
ID=26963579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95930144T ATE196802T1 (de) | 1994-08-03 | 1995-08-02 | Zielspezifische screens und ihre verwendung zur ermittelung von kleinen organischen molekularen pharmakophoren |
Country Status (8)
Country | Link |
---|---|
US (3) | US6010861A (de) |
EP (2) | EP1028315A3 (de) |
JP (1) | JPH10507517A (de) |
AT (1) | ATE196802T1 (de) |
AU (1) | AU3363195A (de) |
CA (1) | CA2196679A1 (de) |
DE (1) | DE69519033T2 (de) |
WO (1) | WO1996004557A2 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6010861A (en) * | 1994-08-03 | 2000-01-04 | Dgi Biotechnologies, Llc | Target specific screens and their use for discovering small organic molecular pharmacophores |
FI962269A (fi) * | 1996-05-30 | 1997-12-01 | Univ Helsinki Licensing | Järjestelmä taudin aiheuttajia estävien peptidien seulomiseksi ja taudin aiheuttajien neutralisointikohtien kuvaamiseksi |
US5928888A (en) * | 1996-09-26 | 1999-07-27 | Aurora Biosciences Corporation | Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities |
US6617114B1 (en) | 1996-10-31 | 2003-09-09 | Karo Bio Ab | Identification of drug complementary combinatorial libraries |
WO1998019162A1 (en) * | 1996-10-31 | 1998-05-07 | Novalon Pharmaceutical Corporation | Identification of drugs using complementary combinatorial libraries |
US6434542B1 (en) * | 1997-04-17 | 2002-08-13 | Smithkline Beecham Corporation | Statistical deconvoluting of mixtures |
GB9722131D0 (en) * | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
CA2312913A1 (en) * | 1997-12-12 | 1999-06-24 | Jeffrey C. Way | Compounds and methods for the inhibition of protein-protein interactions |
US6846625B1 (en) | 1998-01-09 | 2005-01-25 | Cubist Pharmaceuticals, Inc. | Method for identifying validated target and assay combination for drug development |
US6475726B1 (en) | 1998-01-09 | 2002-11-05 | Cubist Pharmaceuticals, Inc. | Method for identifying validated target and assay combinations for drug development |
JP2002530081A (ja) * | 1998-11-18 | 2002-09-17 | ジェネンテック・インコーポレーテッド | 親抗体より高度な結合親和性を持つ抗体変異体 |
US6329145B1 (en) * | 1999-02-09 | 2001-12-11 | Gilead Science, Inc. | Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand |
WO2000053740A1 (fr) * | 1999-03-10 | 2000-09-14 | Ajinomoto Co.,Inc. | Procede de criblage de regulateur d'activite de biomolecule |
US6343257B1 (en) * | 1999-04-23 | 2002-01-29 | Peptor Ltd. | Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library |
CA2402780A1 (en) | 2000-03-29 | 2001-10-04 | Dgi Biotechnologies, L.L.C. | Insulin and igf-1 receptor agonists and antagonists |
US7858559B2 (en) * | 2000-11-17 | 2010-12-28 | University Of Rochester | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
US20050196755A1 (en) * | 2000-11-17 | 2005-09-08 | Maurice Zauderer | In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
US20020150895A1 (en) * | 2000-12-22 | 2002-10-17 | Raymond Wheeler | Method and apparatus for filtering and extending RNA alignment coverage |
US20030104402A1 (en) * | 2001-01-23 | 2003-06-05 | University Of Rochester | Methods of producing or identifying intrabodies in eukaryotic cells |
AU2002240131A1 (en) * | 2001-01-26 | 2002-08-06 | Bioinformatics Dna Codes, Llc | Modular computational models for predicting the pharmaceutical properties of chemical compounds |
US6989236B1 (en) * | 2001-02-09 | 2006-01-24 | University Of Kentucky Research Foundation | Methods to identify plant metabolites |
DE10125258A1 (de) * | 2001-05-23 | 2003-01-09 | November Ag Molekulare Medizin | Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden |
JP4303105B2 (ja) * | 2001-06-28 | 2009-07-29 | ドマンティス リミテッド | 二重特異性リガンドとその利用 |
RU2348647C2 (ru) * | 2001-08-06 | 2009-03-10 | Кьюбист Фармасьютикалз, Инк | Новые депсипептиды и способы их получения |
EP1421379A2 (de) * | 2001-08-07 | 2004-05-26 | Sunesis Pharmaceuticals, Inc. | Cysteinmutanten und verfahren zum nachweis der bindung von liganden an biologische moleküle |
CA2480202A1 (en) * | 2002-04-10 | 2003-10-23 | Transtech Pharma, Inc. | System and method for data analysis, manipulation, and visualization |
US6728593B2 (en) | 2002-06-06 | 2004-04-27 | The Hong Kong Polytechnic University | System for analysis of fabric surface |
US20050033470A1 (en) * | 2002-06-06 | 2005-02-10 | The Hong Kong Polytechnic University | System and method for the three-dimensional analysis and reconstruction of the surface of a thin flexible material |
ATE328906T1 (de) * | 2002-06-28 | 2006-06-15 | Domantis Ltd | Dual-specifische liganden mit erhöhter halbwertszeit |
DE60329500D1 (de) * | 2002-07-12 | 2009-11-12 | Morehouse School Of Medicine | Verfahren zur identifikation von salzempfindlichen personen |
US20040235056A1 (en) * | 2003-05-07 | 2004-11-25 | Mallouk Thomas E. | Method of assembling particle libraries |
GB2406094B (en) * | 2003-09-17 | 2007-06-06 | Antisoma Plc | Modified antibody comprising an amino acid substitution mutation which confers increased stability |
EP1522858A1 (de) * | 2003-10-10 | 2005-04-13 | Jean-Christophe Roegel | Methoden für Selektion von Verbindungen unter Verwendung von Antikörpern mit Aktivität als Agonist, Antagonist oder allosterischen Modulatoren |
US7737327B2 (en) * | 2004-03-09 | 2010-06-15 | The University Of Kentucky Research Foundation | Methods for screening for genes and small molecules that activate mammalian receptor proteins |
FR2869416B1 (fr) * | 2004-04-27 | 2007-01-12 | Centre Nat Rech Scient Cnrse | Procede d'identification d'un ligand capable de moduler selectivement une cascade fonctionnelle impliquant une cible et ses applications pour le criblage a haut-debit de molecules d'interet. |
US20060193849A1 (en) * | 2005-02-25 | 2006-08-31 | Antisoma Plc | Biological materials and uses thereof |
WO2007087266A2 (en) * | 2006-01-23 | 2007-08-02 | Errico Joseph P | Methods and compositions of targeted drug development |
WO2008006087A2 (en) * | 2006-07-07 | 2008-01-10 | The Regents Of The University Of California | Antibodies to conformationally trapped proteins |
EP2045326A1 (de) * | 2007-10-05 | 2009-04-08 | Bayer CropScience AG | Verfahren zum Identifizieren des Interaktionspartners eines Wirkstoffes |
EP2758565A4 (de) * | 2011-09-23 | 2015-03-04 | Merck Sharp & Dohme | Zelloberflächenanzeige von liganden für insulin und/oder des insulin-wachstumsfaktor 1-rezeptors und anwendungen davon |
CA3038846A1 (en) | 2016-10-12 | 2018-04-19 | Janssen Biotech, Inc. | Methods for screening for modulators of gdf15-like biological activity |
CN112924437B (zh) * | 2019-12-06 | 2023-02-21 | 核工业西南物理研究院 | 一种激光诱导击穿光谱绝对定量分析方法 |
KR102580358B1 (ko) * | 2021-06-17 | 2023-09-20 | 한국건설기술연구원 | 임의 위치 계측 및 다중 공간분해능 계측이 가능한 분포형 센싱 기법을 활용한 구조물 건전성 모니터링 장치 및 방법 |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
US4797363A (en) * | 1984-03-19 | 1989-01-10 | Board Of Trustees, University Of Illinois | Bacteriophages as recognition and identification agents |
US5144010A (en) * | 1984-08-27 | 1992-09-01 | The Trustees Of Columbia University In The City Of New York | Method of producing monoclonal auto-anti-idiotypic antibodies |
EP0590689B2 (de) * | 1985-03-30 | 2006-08-16 | KAUFFMAN, Stuart A. | Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren |
US6492107B1 (en) * | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
US4962777A (en) * | 1985-05-21 | 1990-10-16 | Transfresh Corporation | Systems for cleaning and cooling produce |
US5866363A (en) * | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
US4818684A (en) * | 1985-09-10 | 1989-04-04 | The Trustees Of Columbia University In The City Of New York | Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
GB8607679D0 (en) * | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5030576A (en) * | 1986-04-30 | 1991-07-09 | Genentech, Inc. | Receptors for efficient determination of ligands and their antagonists or agonists |
US4859609A (en) * | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
US5260203A (en) * | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
DE3883899T3 (de) * | 1987-03-18 | 1999-04-22 | Sb2, Inc., Danville, Calif. | Geänderte antikörper. |
US5217869A (en) * | 1987-10-13 | 1993-06-08 | Terrapin Technologies, Inc. | Method to produce immunodiagnostic reagents |
US5300425A (en) * | 1987-10-13 | 1994-04-05 | Terrapin Technologies, Inc. | Method to produce immunodiagnostic reagents |
US5133866A (en) * | 1988-03-24 | 1992-07-28 | Terrapin Technologies, Inc. | Method to identify analyte-bending ligands |
US4963263A (en) * | 1988-03-24 | 1990-10-16 | Terrapin Technologies, Inc. | Method of identity analyte-binding peptides |
KR890701761A (ko) * | 1987-10-13 | 1989-12-21 | 제롤드 엘.글릭 | 면역 진단시약의 제조방법 |
CA1339198C (en) * | 1988-02-12 | 1997-08-05 | Gregory Paul Winter | Antibodies to the antigen campath-1 |
WO1989009233A1 (en) * | 1988-03-24 | 1989-10-05 | Terrapin Technologies, Inc. | Molecular sticks for controlling protein conformation |
JP3105898B2 (ja) * | 1988-04-16 | 2000-11-06 | セルテック リミテッド | 組換えdnaタンパクの製造方法 |
US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5663143A (en) * | 1988-09-02 | 1997-09-02 | Dyax Corp. | Engineered human-derived kunitz domains that inhibit human neutrophil elastase |
EP0768377A1 (de) * | 1988-09-02 | 1997-04-16 | Protein Engineering Corporation | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
US5681726A (en) * | 1988-09-19 | 1997-10-28 | Stratagene | Method of double stranded DNA synthesis |
DE68913658T3 (de) * | 1988-11-11 | 2005-07-21 | Stratagene, La Jolla | Klonierung von Immunglobulin Sequenzen aus den variablen Domänen |
US4962277A (en) * | 1988-12-09 | 1990-10-09 | Scripps Clinic And Research Foundation | Deletion analogues of magainin peptides |
US5096815A (en) * | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
US5198346A (en) * | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
US5215963A (en) * | 1989-10-24 | 1993-06-01 | Berlex Laboratories, Inc. | Solubilization and purification of the active gastrin releasing peptide receptor |
WO1991010907A1 (en) * | 1990-01-22 | 1991-07-25 | Synbiotics Corporation | Pharmacologically active compound screening antibodies and hierarchical cluster analysis |
US5427908A (en) * | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9012995D0 (en) * | 1990-06-11 | 1990-08-01 | Celltech Ltd | Multivalent antigen-binding proteins |
US5723286A (en) * | 1990-06-20 | 1998-03-03 | Affymax Technologies N.V. | Peptide library and screening systems |
GB9015198D0 (en) * | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
AU665190B2 (en) * | 1990-07-10 | 1995-12-21 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
GB9016299D0 (en) * | 1990-07-25 | 1990-09-12 | Brien Caroline J O | Binding substances |
US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
US5871974A (en) * | 1990-09-28 | 1999-02-16 | Ixsys Inc. | Surface expression libraries of heteromeric receptors |
US5698426A (en) * | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
IL99553A0 (en) * | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing oligonucleotides linked to expression elements,a kit for the preparation of vectors useful for the expression of a diverse population of random peptides and methods utilizing the same |
IL99552A0 (en) * | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof |
US5770434A (en) * | 1990-09-28 | 1998-06-23 | Ixsys Incorporated | Soluble peptides having constrained, secondary conformation in solution and method of making same |
AU9166691A (en) * | 1990-12-20 | 1992-07-22 | Ixsys, Inc. | Optimization of binding proteins |
AU648630B2 (en) * | 1990-12-21 | 1994-04-28 | Creative Biomolecules, Inc. | Biosynthetic PDGF antagonists |
US5322699A (en) * | 1991-02-04 | 1994-06-21 | The Rockefeller University | Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1) |
EP0523949B1 (de) * | 1991-07-15 | 2003-06-25 | The Wellcome Foundation Limited | Herstellung von Antikörpern |
NL9101290A (nl) * | 1991-07-23 | 1993-02-16 | Stichting Rega V Z W | Recombinant dna-molecuul voor de expressie van een fv-fragment van een antilichaam. |
US5230998A (en) * | 1991-07-25 | 1993-07-27 | Neurath Alexander R | Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120 |
US5270170A (en) * | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
ATE463573T1 (de) * | 1991-12-02 | 2010-04-15 | Medimmune Ltd | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
US5488099A (en) * | 1992-03-06 | 1996-01-30 | Persson, Deceased; Hakan B. | Multifunctional chimeric neurotrophic factors |
US5597920A (en) * | 1992-04-30 | 1997-01-28 | Neurogen Corporation | Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes |
EP0671951A4 (de) * | 1992-12-01 | 1997-05-21 | Protein Design Labs Inc | Humanisierte antikörper, die mit 1-selektine reagieren. |
AU6132994A (en) * | 1993-02-02 | 1994-08-29 | Scripps Research Institute, The | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
ATE529444T1 (de) * | 1994-01-11 | 2011-11-15 | Dyax Corp | Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten |
ATE275583T1 (de) * | 1994-01-11 | 2004-09-15 | Dyax Corp | KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON |
US6057287A (en) * | 1994-01-11 | 2000-05-02 | Dyax Corp. | Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
US6010861A (en) * | 1994-08-03 | 2000-01-04 | Dgi Biotechnologies, Llc | Target specific screens and their use for discovering small organic molecular pharmacophores |
US5602024A (en) * | 1994-12-02 | 1997-02-11 | Synaptic Pharmaceutical Corporation | DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
US5576423A (en) * | 1994-12-02 | 1996-11-19 | Schering Corporation | Antibodies to the slam protein expressed on activated T cells |
US5573423A (en) * | 1995-01-18 | 1996-11-12 | Lin; Kuang-Ts'an | Innovative distribution cable mounting device |
US5605911A (en) * | 1995-01-31 | 1997-02-25 | Washington University | Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH) |
US5780426A (en) * | 1995-06-07 | 1998-07-14 | Ixsys, Incorporated | Fivemer cyclic peptide inhibitors of diseases involving αv β3 |
US5767071A (en) * | 1995-06-07 | 1998-06-16 | Ixsys Incorporated | Sevenmer cyclic peptide inhibitors of diseases involving αv β3 |
US6084062A (en) * | 1996-03-20 | 2000-07-04 | Dyax Corp. | Polypeptides that bind to tissue plasminogen activator (tPA) |
US5862514A (en) * | 1996-12-06 | 1999-01-19 | Ixsys, Inc. | Method and means for synthesis-based simulation of chemicals having biological functions |
US6387879B1 (en) * | 1997-12-15 | 2002-05-14 | Dgi Biotechnologies, Inc. | Compounds that bind growth to hormone receptor |
-
1995
- 1995-06-07 US US08/473,105 patent/US6010861A/en not_active Expired - Fee Related
- 1995-08-02 AT AT95930144T patent/ATE196802T1/de not_active IP Right Cessation
- 1995-08-02 JP JP8506821A patent/JPH10507517A/ja not_active Ceased
- 1995-08-02 WO PCT/US1995/010182 patent/WO1996004557A2/en active IP Right Grant
- 1995-08-02 EP EP00111315A patent/EP1028315A3/de not_active Ceased
- 1995-08-02 EP EP95930144A patent/EP0774118B1/de not_active Expired - Lifetime
- 1995-08-02 AU AU33631/95A patent/AU3363195A/en not_active Abandoned
- 1995-08-02 DE DE69519033T patent/DE69519033T2/de not_active Expired - Fee Related
- 1995-08-02 CA CA002196679A patent/CA2196679A1/en not_active Abandoned
-
1999
- 1999-10-05 US US09/412,831 patent/US20030092057A1/en not_active Abandoned
-
2003
- 2003-10-08 US US10/681,669 patent/US20040072271A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69519033T2 (de) | 2001-05-17 |
US20040072271A1 (en) | 2004-04-15 |
EP1028315A3 (de) | 2004-01-02 |
EP0774118B1 (de) | 2000-10-04 |
US6010861A (en) | 2000-01-04 |
WO1996004557A2 (en) | 1996-02-15 |
US20030092057A1 (en) | 2003-05-15 |
EP0774118A2 (de) | 1997-05-21 |
WO1996004557A3 (en) | 1996-04-25 |
CA2196679A1 (en) | 1996-02-15 |
AU3363195A (en) | 1996-03-04 |
JPH10507517A (ja) | 1998-07-21 |
DE69519033D1 (de) | 2000-11-09 |
EP1028315A2 (de) | 2000-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE196802T1 (de) | Zielspezifische screens und ihre verwendung zur ermittelung von kleinen organischen molekularen pharmakophoren | |
ATE522610T1 (de) | Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen | |
ATE529509T1 (de) | Selektion von proteinen unter verwendung von rna- protein-fusionen | |
ATE204290T1 (de) | Zusammensetzungen und verfahren zur immobilisierung von nukleinsäure auf festträgern | |
DK1870465T3 (da) | Fremgangsmåde til chemokinreceptor 88C | |
ATE361364T1 (de) | Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen | |
DE122008000039I1 (de) | Modularer Zusammenbau von Antikorpergenen, dadurchhergestellte Antikorper und deren Anwendungen. | |
DE69714654D1 (de) | Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen | |
DK0630405T3 (da) | Hidtil ukendt 7-transmembranreceptor benævnt V28 | |
ATE335498T1 (de) | Methode mit hoher durchsatzrate zur funktionellen klassifizierung von in einem genomischen versuchsansatz identifizierten proteinen | |
DE69730235D1 (de) | Neuartige Verfahren und Zusammensetzungen zur Entdeckung von neuen multimerischen Molekülen, basierend auf einer kombinatorisichen Bibliothek | |
DE58909458D1 (de) | Antigenkonstrukte von "Major Histocompatibility Complex" Klasse I Antigenen mit spezifischen Trägermolekülen, ihre Herstellung und Verwendung. | |
DE69435038D1 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
FR10C0048I2 (fr) | Nouvelle proteine et methode de production associee | |
DE69932712D1 (de) | Vorhersage über die rezeptor-modulierende wirkung von verbindungen | |
DE69612457D1 (de) | Screening-Verfahren zur Ligand-Identifizierung von Zielproteinen | |
DK0845005T3 (da) | TRAF-inhibitorer | |
NO904160L (no) | Ligandholdig medium for kromatografisk separering, og fremgangsmaate til fremstilling av mediet. | |
EP0574414A4 (de) | Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |